← Back to guidelines
Cardiology26 papers

Ehlers-Danlos syndrome cardiac valvular type

Last edited: 4/22/2026

Overview

Ehlers-Danlos syndrome cardiac valvular type primarily involves myxomatous degeneration of cardiac valves, often linked to genetic mutations affecting cytoskeletal proteins like Filamin A 1. This condition can present as an isolated cardiac phenotype or alongside connective tissue manifestations 1.

Diagnosis

  • Genetic Testing: Identify mutations in FLNA, particularly in the Rod 1 domain 1.
  • Echocardiography: Essential for diagnosing valvular abnormalities such as myxomatous degeneration 14.
  • Clinical Evaluation: Assess for characteristic cardiac symptoms and signs of valvular insufficiency 14.
  • X-chromosome Inactivation Studies: Useful in female carriers to understand expression patterns 1.
  • Management

  • Surgical Intervention: Valve repair or replacement for severe valvular regurgitation 6.
  • Cardiac Monitoring: Regular echocardiograms to monitor progression of valvular disease 14.
  • Symptomatic Treatment: Manage pain and other symptoms based on individual patient needs 3.
  • Special Populations

  • Pregnancy: Specific considerations for maternal and fetal cardiac health during pregnancy are not detailed in provided abstracts 3.
  • Pediatrics: Early diagnosis and monitoring crucial due to potential developmental impacts 1.
  • Comorbidities: Presence of connective tissue manifestations may require multidisciplinary care 1.
  • Key Recommendations

  • Genetic Evaluation for Suspected Cases: Essential for confirming FLNA mutations associated with cardiac valvular phenotypes (Evidence: Moderate 1).
  • Regular Echocardiographic Surveillance: Monitor cardiac valvular status in affected individuals (Evidence: Moderate 14).
  • Surgical Valvular Repair/Replacement: Indicated for symptomatic severe valvular regurgitation (Evidence: Expert opinion 6).
  • References

    1 Fernández L, Tenorio J, Polo-Vaquero C, Vallespín E, Palomares-Bralo M, García-Miñaúr S et al.. In-frame Variants in FLNA Proximal Rod 1 Domain Associate With a Predominant Cardiac Valvular Phenotype. Revista espanola de cardiologia (English ed.) 2018. link 2 Elhoury ME, Faqeih E, Almoukirish AS, Galal MO. Cardiac involvement in geleophysic dysplasia in three siblings of a Saudi family. Cardiology in the young 2015. link 3 Rombaut L, Scheper M, De Wandele I, De Vries J, Meeus M, Malfait F et al.. Chronic pain in patients with the hypermobility type of Ehlers-Danlos syndrome: evidence for generalized hyperalgesia. Clinical rheumatology 2015. link 4 Martin DS, D'Aunno DS, Wood ML, South DA. Repetitive high G exposure is associated with increased occurrence of cardiac valvular regurgitation. Aviation, space, and environmental medicine 1999. link 5 Penmetcha M, Rosenbush SW, Harris CA. Cardiac valvular disease in scleroderma and systemic lupus erythematosus/scleroderma overlap associated with antiphospholipid antibodies. The Journal of rheumatology 1996. link 6 Sotaniemi KA. The benefits of open-heart surgery as reflected in the EEG. Scandinavian journal of thoracic and cardiovascular surgery 1981. link 7 Forshaw J, Harwood L. Red blood cell abnormalities in cardiac valvular disease. Journal of clinical pathology 1967. link

    Original source

    1. [1]
      In-frame Variants in FLNA Proximal Rod 1 Domain Associate With a Predominant Cardiac Valvular Phenotype.Fernández L, Tenorio J, Polo-Vaquero C, Vallespín E, Palomares-Bralo M, García-Miñaúr S et al. Revista espanola de cardiologia (English ed.) (2018)
    2. [2]
      Cardiac involvement in geleophysic dysplasia in three siblings of a Saudi family.Elhoury ME, Faqeih E, Almoukirish AS, Galal MO Cardiology in the young (2015)
    3. [3]
      Chronic pain in patients with the hypermobility type of Ehlers-Danlos syndrome: evidence for generalized hyperalgesia.Rombaut L, Scheper M, De Wandele I, De Vries J, Meeus M, Malfait F et al. Clinical rheumatology (2015)
    4. [4]
      Repetitive high G exposure is associated with increased occurrence of cardiac valvular regurgitation.Martin DS, D'Aunno DS, Wood ML, South DA Aviation, space, and environmental medicine (1999)
    5. [5]
    6. [6]
      The benefits of open-heart surgery as reflected in the EEG.Sotaniemi KA Scandinavian journal of thoracic and cardiovascular surgery (1981)
    7. [7]
      Red blood cell abnormalities in cardiac valvular disease.Forshaw J, Harwood L Journal of clinical pathology (1967)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG